Hepatitis b, chronic Clinical Trials
Conditions / Hepatitis b, chronic
Delta Trials catalogs 233 clinical trials for Hepatitis b, chronic in its publicly accessible dataset. Within this set, 14 currently recruiting participants and 130 trials have reached completion. This research occurs across 786 participating sites around the world. An additional 89 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 20 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
233
Total Trials
14
Recruiting
130
Completed
89
Other Active
20
Terminated since 2020
786
Study Locations
Browse by location (786 total)
- Guangzhou, China 45 trialsAll trials in Guangzhou, China
- Seoul, South Korea 42 trialsAll trials in Seoul, South Korea
- Beijing, China 41 trialsAll trials in Beijing, China
- Shanghai, China 36 trialsAll trials in Shanghai, China
- Taipei, Taiwan 29 trialsAll trials in Taipei, Taiwan
- Taipei, Taiwan 29 trialsAll trials in Taipei, Taiwan
- Changchun, China 25 trialsAll trials in Changchun, China
- Kaohsiung City, Taiwan 24 trialsAll trials in Kaohsiung City, Taiwan
- Wuhan, China 24 trialsAll trials in Wuhan, China
- Hong Kong, Hong Kong 23 trialsAll trials in Hong Kong, Hong Kong
- Chongqing, China 23 trialsAll trials in Chongqing, China
- London, United Kingdom 23 trialsAll trials in London, United Kingdom
- Xi’an, China 22 trialsAll trials in Xi’an, China
- Nanjing, China 21 trialsAll trials in Nanjing, China
- Hangzhou, China 21 trialsAll trials in Hangzhou, China
- Auckland, New Zealand 19 trialsAll trials in Auckland, New Zealand
- Bangkok, Thailand 19 trialsAll trials in Bangkok, Thailand
- Bangkok, Thailand 19 trialsAll trials in Bangkok, Thailand
- Clichy, France 18 trialsAll trials in Clichy, France
- Taichung, Taiwan 18 trialsAll trials in Taichung, Taiwan